LILLY PARLLAKU: Open Payments
NPI 1851630735 · VILLANOVA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 45 payments from 15 companies in 2025. Trend: 2023 $891 · 2024 $1,338 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $157 |
| ABBVIE INC. | 13 | $143 |
| PFIZER INC. | 4 | $92 |
| LEO Pharma Inc. | 4 | $91 |
| Botanix SB Inc | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| GENZYME CORPORATION | 2 | $63 |
| Janssen Biotech, Inc. | 3 | $62 |
| Incyte Corporation | 2 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
Products named: DYSPORT, DUPIXENT, CIBINQO, ADBRY, SOFDRA, COSENTYX, TREMFYA, RINVOQ.
Industry payments across PA — which companies pay providers there.
